Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Viscum album lipophilic extract
- Development stage
- Preclinical
- Lead developer
- Universität Witten
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Viscum album lipophilic extract (VALE) is a topical botanical drug derived from European mistletoe (*Viscum album* L.), specifically formulated as a 10% resin cream. Developed by researchers at the Universität Witten/Herdecke and manufactured by Iscador AG, it contains pharmacologically active pentacyclic triterpenes, including oleanolic acid, betulinic acid, and ursolic acid. These components exert antitumor, immunomodulatory, and anti-inflammatory effects by inhibiting tumor cell growth and inducing apoptosis. The drug is primarily investigated for the treatment of non-melanoma skin cancers and precancerous lesions, such as actinic keratosis, cutaneous squamous cell carcinoma, and basal cell carcinoma.
- Brand names
- Viscum album Herba Extractum resinosum 10%, Crème
- Other names
- VALEmistletoe resin creamlipophilic Viscum album extract
Beyond the preview
Go deeper on Viscum album lipophilic extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Viscum album lipophilic extract.